Aging (Albany NY):糖尿病性视神经病变患者额中回高信号:低频波动的动态振幅研究

2022-02-21 从医路漫漫 MedSci原创

糖尿病(DM)是一种常见的慢性病,其患病率持续上升。

背景:糖尿病(DM)是一种常见的慢性病,其患病率持续上升。随着糖尿病的进展,神经病变已成为糖尿病患者最常见的并发症。糖尿病性视神经病变(DIN)是糖尿病的主要慢性并发症之一,包括糖尿病乳头病变、视盘新生血管、前部缺血性视神经病变和视神经萎缩。糖尿病视网膜病变(DR)患者中DON的患病率为38.4%。由于DON的形式多种多样,很难诊断,因此它会严重威胁糖尿病患者的视力,影响患者的生活质量,这突显了眼科医生评估的必要性。根据最近的报道,糖尿病患者的高血糖会减少局部组织血流量,这可能会影响视神经的新陈代谢。与DON相关的主要机制包括多元醇途径的激活、炎症反应和氧化应激。此外,随着疾病的发展,视神经会出现不可逆转的萎缩,最终导致失明。

目的:本研究的目的是利用低频波动的动态幅度(DALFF)探讨DON患者脑活动的动态变化。

总共有22名DON患者和22名健康对照者入选。在所有参与者中使用DALFF方法来研究两组之间动态内在脑活动的差异。

结果:与HCS组相比,DON组右侧额中回DALFF变异性显著增加(P<0.01)。相反,DON患者右侧楔前叶DALFF变异性明显降低(P<0.01)。DON患者右侧额中回HADS评分与DALF值呈显著负相关(焦虑r=0.6404,P<0.0 1;抑郁r=-0.6346,P<0.0 1;HADS、医院焦虑抑郁量表)。

图1糖尿病视神经病变一例,行眼底照相(A)和荧光眼底血管造影(B)。观察视神经周围出血(红色箭头)和视盘水肿(白色箭头)。

表1。本研究参与者的临床特征。

图2.DON患者和HCS患者之间不同dALF值的比较。观察了DON患者dALFF变异的空间分布模式。DON患者(A)的平均dALFF方差图。与HCS相比,DON患者MRG_R dALFF值增高,PREC_R dALFF值降低。它们在冠状位、矢状位和横位的代表性分布(B)和三维分布(C)。两组间的dALFF值比较采用双样本t检验。DON患者与HCS(D)患者之间改变的dALFF平均值。*代表P<0.01。暖色区域表示两组中较高的值,而冷色区域表示较低的值。缩写:dALFF,低频波动的动态幅度;DON,糖尿病视神经病变;HCS,健康对照;MFG,额中回;PREC,楔前;R,右;L,左。

表2.DON和HCS患者之间dALFF值显著不同的脑区

图3.改变的大脑区域的平均dALFF值的ROC曲线分析。(B)DON<HCS,PREC_R的ROC曲线下面积为0.858(P<0.0001;95%CI:0.737-0.979)。缩写:ROC,受试者工作特征;DALFF,低频波动的动态幅度;DON,糖尿病性视神经病变;HCS,健康对照;AUC,曲线下面积;R,右;

图4。MFG_R的dALFF值与临床行为的相关性。采用Pearson相关分析确定显著的dALF值与HDS评分之间的线性关系。焦虑评分与MFG_R的DALFF值呈负相关(r=−0.6406,P<0.0 1),抑郁评分与MFG_R的DALF值呈负相关(r=−0.6346,P<0.0 1)。缩写:dALFF,低频波动的动态幅度;MFG,额中回;R,右;AS,焦虑评分;DS,抑郁评分。

图5右侧额中回大脑dalff值与情绪状态的关系。与HCS相比,DON患者右侧额中回dALFF值降低,更易出现焦虑、抑郁情绪。缩写:dALFF,低频波动的动态幅度;HCS,健康对照组;DON,糖尿病视神经病变。

结论:在DON患者大脑特定区域观察到DALFF的异常变异,有助于鉴别DON和HCS,提高对DON的认识,右侧额叶中回高信号可能是诊断DON的潜在指标。

原文出处:Yang L,  Xiao A,  Li QY,et al.Hyperintensities of middle frontal gyrus in patients with diabetic optic neuropathy: a dynamic amplitude of low-frequency fluctuation study.Aging (Albany NY) 2022 Feb 04;14

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1926551, encodeId=e9cb19265511b, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Apr 12 07:27:30 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667027, encodeId=e949166e0275f, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Nov 28 16:27:30 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950851, encodeId=de77195085176, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Sat Oct 15 13:27:30 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196146, encodeId=ed3d1196146b3, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:43:26 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193937, encodeId=f5cf119393e2e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Wed Feb 16 10:15:50 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491434, encodeId=45b51491434f2, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500427, encodeId=b9ab150042e30, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1926551, encodeId=e9cb19265511b, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Apr 12 07:27:30 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667027, encodeId=e949166e0275f, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Nov 28 16:27:30 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950851, encodeId=de77195085176, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Sat Oct 15 13:27:30 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196146, encodeId=ed3d1196146b3, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:43:26 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193937, encodeId=f5cf119393e2e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Wed Feb 16 10:15:50 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491434, encodeId=45b51491434f2, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500427, encodeId=b9ab150042e30, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=)]
    2022-11-28 gj0740
  3. [GetPortalCommentsPageByObjectIdResponse(id=1926551, encodeId=e9cb19265511b, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Apr 12 07:27:30 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667027, encodeId=e949166e0275f, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Nov 28 16:27:30 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950851, encodeId=de77195085176, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Sat Oct 15 13:27:30 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196146, encodeId=ed3d1196146b3, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:43:26 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193937, encodeId=f5cf119393e2e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Wed Feb 16 10:15:50 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491434, encodeId=45b51491434f2, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500427, encodeId=b9ab150042e30, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1926551, encodeId=e9cb19265511b, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Apr 12 07:27:30 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667027, encodeId=e949166e0275f, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Nov 28 16:27:30 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950851, encodeId=de77195085176, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Sat Oct 15 13:27:30 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196146, encodeId=ed3d1196146b3, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:43:26 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193937, encodeId=f5cf119393e2e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Wed Feb 16 10:15:50 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491434, encodeId=45b51491434f2, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500427, encodeId=b9ab150042e30, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=)]
    2022-02-22 ms2000001545439177

    受益匪浅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1926551, encodeId=e9cb19265511b, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Apr 12 07:27:30 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667027, encodeId=e949166e0275f, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Nov 28 16:27:30 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950851, encodeId=de77195085176, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Sat Oct 15 13:27:30 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196146, encodeId=ed3d1196146b3, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:43:26 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193937, encodeId=f5cf119393e2e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Wed Feb 16 10:15:50 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491434, encodeId=45b51491434f2, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500427, encodeId=b9ab150042e30, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=)]
    2022-02-16 ms9000002100948639

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1926551, encodeId=e9cb19265511b, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Apr 12 07:27:30 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667027, encodeId=e949166e0275f, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Nov 28 16:27:30 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950851, encodeId=de77195085176, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Sat Oct 15 13:27:30 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196146, encodeId=ed3d1196146b3, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:43:26 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193937, encodeId=f5cf119393e2e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Wed Feb 16 10:15:50 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491434, encodeId=45b51491434f2, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500427, encodeId=b9ab150042e30, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1926551, encodeId=e9cb19265511b, content=<a href='/topic/show?id=3ce590e1692' target=_blank style='color:#2F92EE;'>#视神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90716, encryptionId=3ce590e1692, topicName=视神经病变)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=991e83, createdName=wincls, createdTime=Tue Apr 12 07:27:30 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667027, encodeId=e949166e0275f, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Mon Nov 28 16:27:30 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950851, encodeId=de77195085176, content=<a href='/topic/show?id=20101021e97e' target=_blank style='color:#2F92EE;'>#高信号#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102179, encryptionId=20101021e97e, topicName=高信号)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Sat Oct 15 13:27:30 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196146, encodeId=ed3d1196146b3, content=受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede65630636, createdName=ms2000001545439177, createdTime=Tue Feb 22 16:43:26 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193937, encodeId=f5cf119393e2e, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae36495381, createdName=ms9000002100948639, createdTime=Wed Feb 16 10:15:50 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1491434, encodeId=45b51491434f2, content=<a href='/topic/show?id=5316e4387aa' target=_blank style='color:#2F92EE;'>#神经病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74387, encryptionId=5316e4387aa, topicName=神经病)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500427, encodeId=b9ab150042e30, content=<a href='/topic/show?id=ecdfe438970' target=_blank style='color:#2F92EE;'>#神经病变#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74389, encryptionId=ecdfe438970, topicName=神经病变)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea69427176, createdName=lingaifan, createdTime=Wed Feb 16 04:27:30 CST 2022, time=2022-02-16, status=1, ipAttribution=)]

相关资讯

EOTT:GDF15: 1型糖尿病的潜在治疗靶点

1型糖尿病(T1D)是一种自身免疫性疾病,其特征是胰腺中产生胰岛素的β细胞遭到破坏。

DOM:瑞典2型糖尿病控制欠佳对纳税人的公共经济负担的影响

评估因糖尿病相关并发症导致的2型糖尿病(T2D)患者未能达到糖化血红蛋白指标的瑞典纳税人的财政负担。

CDSR:低碳水化合物饮食与平衡碳水化合物饮食在降低体重和心血管风险方面的作用

《2017年全球营养报告》估计,全球有20亿成年人超重或肥胖,4100万儿童超重。

BMC Med:口服糖尿病药物对亚洲人初级保健中糖化血红蛋白 (HbA1c) 的影响

口服降糖药(OADs)可显著降低糖化血红蛋白(HbA1c)水平。然而,生活方式改变和OAD依从性的差异影响了它们对血糖控制的实际效果。

Diabetes:Teplizumab治疗后3个月内抑制1型糖尿病高危人群的快速代谢下降

为了更有效地开展1型糖尿病预防试验,需要提供治疗效果早期识别的终点。

BMC Med:通过预测血糖反应的个性化饮食对新诊断的T2 DM患者血糖控制和代谢健康的影响

饮食调整对于新诊断的2型糖尿病(T2DM)的治疗和预防其健康并发症至关重要,但许多患者仅靠饮食无法达到临床目标。